Chronic Myeloid Leukemia

Klappentext Chronic Myeloid Leukemia (CML) remains a key model for the improved understanding of the pathophysiology of a malignancy at a molecular level and has been used by researchers to develop a variety of therapies and therapeutic assessment methods. This concise! readable guide assembles and synthesizes the latest developments and trends in the treatment of CML and provides an authoritative and convenient summary of the latest progress in imatinib trials! the molecular monitoring of CML responses! and the engineering of new therapies to overcome resistance and improve patient care. Zusammenfassung Chronic Myeloid Leukemia (CML) remains a key model for the improved understanding of the pathophysiology of a malignancy at a molecular level and has been used by researchers to develop a variety of therapies and therapeutic assessment methods. This concise, readable guide assembles and synthesizes the latest developments and tr

Détails du produit

• Auteurs: Jorge Cortes, Jorge (Md Anderson Cancer Center Cortes, Jorge Deininger Cortes, Jorge E. Deininger Cortes, Jorge Cortes
• Collaboration: Jorge Cortes (Editeur), Jorge (Md Anderson Cancer Center Cortes (Editeur), Jorge E. Cortes (Editeur), Cortes Jorge (Editeur), Michael Deininger (Editeur), Michael (Oregon Health Sciences University Deininger (Editeur), Deininger Michael (Editeur)
• Edition: Taylor & Francis Ltd.
• Langues: Anglais
• Format d'édition: Livre Relié
• Sortie: 13.12.2006
• EAN: 9780849379550
• ISBN: 978-0-8493-7955-0
• Pages: 172
• Catégories: Littérature spécialisée > Dictionnaire, ouvrages de référence; Sciences naturelles, médecine, informatique, technique > Médecine > Spécialités cliniques; MEDICAL / General, MEDICAL / Pediatrics, MEDICAL / Pathophysiology, Oncology, Paediatric medicine, MEDICAL / Oncology / General, Paediatric medicine / child and adolescent medicine